Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Greene

Showing results (401-410 of 410) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 410 results.
Diabetes Care|August 11, 2017
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized TrialAdam P Bress, Jordan B King, Kathryn E Kreider, et al.
The New England Journal of Medicine|May 22, 2009
Effect of dipyridamole plus aspirin on hemodialysis graft patencyBradley S Dixon, Gerald J Beck, Miguel A Vazquez, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2017
Effects of Intensive BP Control in CKDAlfred K Cheung, Mahboob Rahman, David M Reboussin, et al.
The New England Journal of Medicine|September 23, 2021
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without RaceLesley A Inker, Nwamaka D Eneanya, Josef Coresh, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Integrative Clinical-Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial ImprovementEzra Johnson, Joseph R Visker, Ben J Brintz, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodologyPaul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
Kidney International|February 4, 2011
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohortsBrad C Astor, Kunihiro Matsushita, Ron T Gansevoort, et al.
Kidney International|July 22, 2011
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialMichael V Rocco, Robert S Lockridge, Gerald J Beck, et al.
Pageof 41

Showing results (401-410 of 410) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 410 results.
Diabetes Care|August 11, 2017
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized TrialAdam P Bress, Jordan B King, Kathryn E Kreider, et al.
The New England Journal of Medicine|May 22, 2009
Effect of dipyridamole plus aspirin on hemodialysis graft patencyBradley S Dixon, Gerald J Beck, Miguel A Vazquez, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2017
Effects of Intensive BP Control in CKDAlfred K Cheung, Mahboob Rahman, David M Reboussin, et al.
The New England Journal of Medicine|September 23, 2021
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without RaceLesley A Inker, Nwamaka D Eneanya, Josef Coresh, et al.
The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Integrative Clinical-Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial ImprovementEzra Johnson, Joseph R Visker, Ben J Brintz, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 24, 2012
Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodologyPaul M Palevsky, Bruce A Molitoris, Mark D Okusa, et al.
Kidney International|February 4, 2011
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohortsBrad C Astor, Kunihiro Matsushita, Ron T Gansevoort, et al.
Kidney International|July 22, 2011
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialMichael V Rocco, Robert S Lockridge, Gerald J Beck, et al.
Pageof 41